Literature DB >> 21281587

All-atom molecular dynamics simulations reveal significant differences in interaction between antimycin and conserved amino acid residues in bovine and bacterial bc1 complexes.

Oleksandr Kokhan1, Vladimir P Shinkarev2.   

Abstract

Antimycin A is the most frequently used specific and powerful inhibitor of the mitochondrial respiratory chain. We used all-atom molecular dynamics (MD) simulations to study the dynamic aspects of the interaction of antimycin A with the Q(i) site of the bacterial and bovine bc(1) complexes embedded in a membrane. The MD simulations revealed considerable conformational flexibility of antimycin and significant mobility of antimycin, as a whole, inside the Q(i) pocket. We conclude that many of the differences in antimycin binding observed in high-resolution x-ray structures may have a dynamic origin and result from fluctuations of protein and antimycin between multiple conformational states of similar energy separated by low activation barriers, as well as from the mobility of antimycin within the Q(i) pocket. The MD simulations also revealed a significant difference in interaction between antimycin and conserved amino acid residues in bovine and bacterial bc(1) complexes. The strong hydrogen bond between antimycin and conserved Asp-228 (bovine numeration) was observed to be frequently broken in the bacterial bc(1) complex and only rarely in the bovine bc(1) complex. In addition, the distances between antimycin and conserved His-201 and Lys-227 were consistently larger in the bacterial bc(1) complex. The observed differences could be responsible for a weaker interaction of antimycin with the bacterial bc(1) complex.
Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281587      PMCID: PMC3030202          DOI: 10.1016/j.bpj.2010.12.3705

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  31 in total

1.  The Q-cycle - A Personal Perspective.

Authors:  Antony R Crofts
Journal:  Photosynth Res       Date:  2004       Impact factor: 3.573

2.  Inhibitor-complexed structures of the cytochrome bc1 from the photosynthetic bacterium Rhodobacter sphaeroides.

Authors:  Lothar Esser; Maria Elberry; Fei Zhou; Chang-An Yu; Linda Yu; Di Xia
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

Review 3.  The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex.

Authors:  B L Trumpower
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

Review 4.  The mechanism of action of the respiratory inhibitor, antimycin.

Authors:  E C Slater
Journal:  Biochim Biophys Acta       Date:  1973-12-07

5.  Structural factors of antimycin A molecule required for inhibitory action.

Authors:  N Tokutake; H Miyoshi; T Satoh; T Hatano; H Iwamura
Journal:  Biochim Biophys Acta       Date:  1994-05-18

6.  Inhibition of electron transport of rat-liver mitochondria by synthesized antimycin A analogs.

Authors:  N Tokutake; H Miyoshi; H Nakazato; H Iwamura
Journal:  Biochim Biophys Acta       Date:  1993-05-06

Review 7.  Molecular basis of resistance to cytochrome bc1 inhibitors.

Authors:  Nick Fisher; Brigitte Meunier
Journal:  FEMS Yeast Res       Date:  2007-12-17       Impact factor: 2.796

8.  A model of antimycin A binding based on structure-activity studies of synthetic antimycin A analogues.

Authors:  H Miyoshi; N Tokutake; Y Imaeda; T Akagi; H Iwamura
Journal:  Biochim Biophys Acta       Date:  1995-04-26

9.  Mutational analysis of the mouse mitochondrial cytochrome b gene.

Authors:  N Howell; K Gilbert
Journal:  J Mol Biol       Date:  1988-10-05       Impact factor: 5.469

10.  Mutations conferring resistance to quinol oxidation (Qz) inhibitors of the cyt bc1 complex of Rhodobacter capsulatus.

Authors:  F Daldal; M K Tokito; E Davidson; M Faham
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.